Variant report
Variant | esv3401563 |
---|---|
Chromosome Location | chr4:7118151-7122649 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:60)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr4:7122098-7122348 | K562 | blood: | n/a | n/a |
2 | CHD2 | chr4:7122096-7122393 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CHD2 | chr4:7122140-7122405 | K562 | blood: | n/a | n/a |
4 | EGR1 | chr4:7120193-7120363 | K562 | blood: | n/a | n/a |
5 | EP300 | chr4:7122082-7122378 | K562 | blood: | n/a | n/a |
6 | FOS | chr4:7122044-7122418 | K562 | blood: | n/a | n/a |
7 | GTF2F1 | chr4:7122459-7122546 | K562 | blood: | n/a | n/a |
8 | IRF1 | chr4:7122124-7122424 | K562 | blood: | n/a | n/a |
9 | JUND | chr4:7122193-7122387 | K562 | blood: | n/a | n/a |
10 | MAX | chr4:7122290-7122418 | A549 | lung: | n/a | n/a |
11 | MAX | chr4:7122191-7122467 | NB4 | blood: | n/a | n/a |
12 | MYC | chr4:7121893-7122223 | K562 | blood: | n/a | n/a |
13 | NFYA | chr4:7122039-7122442 | Hela-S3 | cervix: | n/a | chr4:7122216-7122234 |
14 | NFYA | chr4:7121956-7122580 | K562 | blood: | n/a | chr4:7122216-7122234 |
15 | NFYB | chr4:7122015-7122469 | Hela-S3 | cervix: | n/a | chr4:7122222-7122237 |
16 | NFYB | chr4:7121909-7122475 | GM12878 | blood: | n/a | chr4:7122222-7122237 |
17 | NFYB | chr4:7121953-7122650 | K562 | blood: | n/a | chr4:7122222-7122237 |
18 | POLR2A | chr4:7122069-7122244 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr4:7118787-7119028 | K562 | blood: | n/a | n/a |
20 | POLR2A | chr4:7119288-7119629 | K562 | blood: | n/a | n/a |
21 | RCOR1 | chr4:7122404-7122691 | K562 | blood: | n/a | n/a |
22 | RFX5 | chr4:7121881-7122792 | SK-N-SH | brain: | n/a | chr4:7122277-7122292 |
23 | RFX5 | chr4:7122195-7122394 | H1-hESC | embryonic stem cell: | n/a | chr4:7122277-7122292 |
24 | RFX5 | chr4:7122255-7122407 | HepG2 | liver: | n/a | chr4:7122277-7122292 |
25 | RFX5 | chr4:7122156-7122356 | K562 | blood: | n/a | chr4:7122277-7122292 |
26 | SP1 | chr4:7122027-7122493 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | SP1 | chr4:7122000-7122484 | A549 | lung: | n/a | n/a |
28 | SP1 | chr4:7122100-7122427 | K562 | blood: | n/a | n/a |
29 | SP1 | chr4:7122018-7122509 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | SP1 | chr4:7122063-7122367 | GM12878 | blood: | n/a | n/a |
31 | SP1 | chr4:7122061-7122484 | GM12878 | blood: | n/a | n/a |
32 | SP1 | chr4:7122027-7122483 | A549 | lung: | n/a | n/a |
33 | SP2 | chr4:7122174-7122353 | K562 | blood: | n/a | n/a |
34 | SP2 | chr4:7122052-7122438 | K562 | blood: | n/a | n/a |
35 | TBP | chr4:7122255-7122374 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | TBP | chr4:7122196-7122341 | K562 | blood: | n/a | n/a |
37 | USF1 | chr4:7122138-7122330 | A549 | lung: | n/a | chr4:7122239-7122250 |
38 | USF1 | chr4:7122087-7122439 | H1-hESC | embryonic stem cell: | n/a | chr4:7122239-7122250 |
39 | USF1 | chr4:7122139-7122358 | HepG2 | liver: | n/a | chr4:7122239-7122250 |
40 | USF1 | chr4:7122026-7122475 | H1-hESC | embryonic stem cell: | n/a | chr4:7122239-7122250 |
41 | USF1 | chr4:7121997-7122511 | ECC-1 | luminal epithelium: | n/a | chr4:7122239-7122250 |
42 | USF1 | chr4:7121982-7122548 | HCT-116 | colon: | n/a | chr4:7122239-7122250 |
43 | USF1 | chr4:7122171-7122325 | HepG2 | liver: | n/a | chr4:7122239-7122250 |
44 | USF1 | chr4:7122065-7122421 | A549 | lung: | n/a | chr4:7122239-7122250 |
45 | USF1 | chr4:7122119-7122455 | A549 | lung: | n/a | chr4:7122239-7122250 |
46 | USF1 | chr4:7122080-7122457 | SK-N-SH | brain: | n/a | chr4:7122239-7122250 |
47 | USF1 | chr4:7122047-7122371 | SK-N-SH_RA | brain: | n/a | chr4:7122239-7122250 |
48 | USF1 | chr4:7122002-7122547 | HCT-116 | colon: | n/a | chr4:7122239-7122250 |
49 | USF1 | chr4:7122011-7122418 | K562 | blood: | n/a | chr4:7122239-7122250 |
50 | USF1 | chr4:7122037-7122330 | A549 | lung: | n/a | chr4:7122239-7122250 |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:7121664..7124511-chr4:7134767..7137572,2 | K562 | blood: | |
2 | chr4:7115313..7118277-chr4:7121147..7123527,2 | MCF-7 | breast: | |
3 | chr4:7120740..7122988-chr4:7129086..7130661,2 | MCF-7 | breast: | |
4 | chr4:7103610..7105955-chr4:7121635..7124295,2 | K562 | blood: | |
5 | chr4:7115313..7118277-chr4:7121147..7123527,2 | MCF-7 | breast: | |
6 | chr4:7105423..7108283-chr4:7118442..7120103,2 | MCF-7 | breast: | |
7 | chr4:7114517..7116267-chr4:7117721..7119678,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RN7SKP36 | TF binding region |
ENSG00000245468 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs369133579 | chr4:7118160-7118161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145333496 | chr4:7118178-7118179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573616614 | chr4:7118195-7118196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574650224 | chr4:7118198-7118199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11938272 | chr4:7118207-7118208 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs188599239 | chr4:7118233-7118234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73077716 | chr4:7118269-7118270 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs545310307 | chr4:7118270-7118271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs41486548 | chr4:7118314-7118315 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs527606031 | chr4:7118340-7118341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542609701 | chr4:7118341-7118342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561342897 | chr4:7118354-7118355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531702163 | chr4:7118359-7118360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114406240 | chr4:7118386-7118387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550296124 | chr4:7118388-7118389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35320981 | chr4:7118415-7118416 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs532600042 | chr4:7118434-7118435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534601554 | chr4:7118462-7118463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547598324 | chr4:7118471-7118472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566002051 | chr4:7118482-7118483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs16835121 | chr4:7118488-7118489 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs555061871 | chr4:7118510-7118511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs11938388 | chr4:7118527-7118528 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs181165649 | chr4:7118579-7118580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372504747 | chr4:7118598-7118599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541301506 | chr4:7118620-7118621 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs376743053 | chr4:7118627-7118628 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115313552 | chr4:7118639-7118640 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529258072 | chr4:7118697-7118698 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545196267 | chr4:7118700-7118701 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554013669 | chr4:7118710-7118711 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550524384 | chr4:7118730-7118731 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs147248976 | chr4:7118782-7118783 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542948589 | chr4:7118792-7118793 | Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs113256356 | chr4:7118795-7118796 | Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs531758785 | chr4:7118807-7118808 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs3931345 | chr4:7118808-7118809 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs34925949 | chr4:7118809-7118810 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs565002083 | chr4:7118829-7118830 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs186161333 | chr4:7118837-7118838 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs547535529 | chr4:7118854-7118855 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs34163323 | chr4:7118864-7118865 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs78475968 | chr4:7118871-7118872 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs116119446 | chr4:7118872-7118873 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs551846137 | chr4:7118902-7118903 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs111821493 | chr4:7118920-7118921 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs190478159 | chr4:7118931-7118932 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs142457512 | chr4:7118938-7118939 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs80102498 | chr4:7119010-7119011 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs567177628 | chr4:7119037-7119038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Schizophrenia | 22241247 | CNVD |
Autosomal-dominant microtia | 18179897 | CNVD |
Glioma | 17123091 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Breast cancer | 17133270 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:7105800-7176000 | Weak transcription | Right Atrium | heart |
2 | chr4:7114200-7122000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr4:7114800-7121000 | Weak transcription | Spleen | Spleen |
4 | chr4:7117800-7133400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr4:7118600-7118800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr4:7121000-7124400 | Enhancers | Spleen | Spleen |
7 | chr4:7121600-7121800 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr4:7122000-7122200 | Bivalent/Poised TSS | K562 | blood |
9 | chr4:7122000-7124800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr4:7122200-7122400 | Bivalent Enhancer | K562 | blood |
11 | chr4:7122600-7123000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
12 | chr4:7122600-7123200 | Enhancers | Stomach Smooth Muscle | stomach |
13 | chr4:7122600-7123800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr4:7122600-7123800 | Enhancers | Fetal Muscle Trunk | muscle |
15 | chr4:7122600-7123800 | Enhancers | Lung | lung |